VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3

被引:45
作者
Baroni, Enrico
Biffi, Mauro
Benigni, Fabio
Monno, Antonia
Carlucci, Donatella
Carmeliet, Geert
Bouillon, Roger
D'Ambrosio, Daniele
机构
[1] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium
[2] BioXell SPA, I-20132 Milan, Italy
关键词
apoptosis; maturation; bone marrow; cell surface molecules;
D O I
10.1189/jlb.0506322
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
1,25-Dihydroxyvitamin D-3 [1,25(OH)(2)D-3] is a secosteroid hormone that regulates bone metabolism, controls calcium homeostasis, and possesses immunomodulatory properties. We show here that 1,25(OH)(2)D-3 contributes to the regulation of development and function of mast cells, which play a critical role in several inflammatory disorders. 1,25(OH)(2)D-3 promotes apoptosis and inhibits maturation of mouse bone marrow-derived mast cell precursors. Dose-dependent inhibition of mast cell differentiation by 1,25(OH)2D3 is observed at discrete, intermediate stages of mast cell development, identified by expression of c-kit, Fc epsilon RI, and IL-3 receptor-et chain, and depends on the expression of the vitamin D receptor (VDR). It is important that mast cell progenitors obtained from VDR-ablated mice undergo an accelerated maturation in vitro and give rise to more responsive mast cells than wild-type. Furthermore, histological analysis of mast cell density in peripheral tissues reveals a moderate increase in the number of mast cells in the skin of VDR-deficient mice compared with wild-type animals. These data support the hypothesis of a physiological role of 1,25(OH)2D3 in mast cell development and suggest novel, therapeutic uses of 1,25(OH)2D3 analogs.
引用
收藏
页码:250 / 262
页数:13
相关论文
共 57 条
[1]
Pharmacological induction of tolerogenic dendritic cells and regulatory T cells [J].
Adorini, L ;
Giarratana, N ;
Penna, G .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :127-134
[2]
Intervention in autoimmunity: The potential of vitamin D receptor agonists [J].
Adorini, L .
CELLULAR IMMUNOLOGY, 2005, 233 (02) :115-124
[3]
Human leukemic (HMC-1) mast cells are responsive to 1α,25-dihydroxyvitamin D3:: Selective promotion of ICAM-3 expression and constitutive presence of vitamin D3 receptor [J].
Babina, M ;
Krautheim, M ;
Grützkau, A ;
Henz, BM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) :1104-1110
[4]
Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis [J].
Benigni, F ;
Baroni, E ;
Zecevic, M ;
Zvara, P ;
Streng, T ;
Hedlund, P ;
Colli, E ;
D'Ambrosio, D ;
Andersson, KE .
BJU INTERNATIONAL, 2006, 97 (03) :617-624
[5]
1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells [J].
Boonstra, A ;
Barrat, FJ ;
Crain, C ;
Heath, VL ;
Savelkoul, HFJ ;
O'Garra, A .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :4974-4980
[6]
Mast cells are required for experimental oral allergen-induced diarrhea [J].
Brandt, EB ;
Strait, RT ;
Hershko, D ;
Wang, Q ;
Muntel, EE ;
Scribner, TA ;
Zimmermann, N ;
Finkelman, FD ;
Rothenberg, ME .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (11) :1666-1677
[7]
Vitamin D [J].
Brown, AJ ;
Dusso, A ;
Slatopolsky, E .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (02) :F157-F175
[8]
Anti-IgE as a mast cell-stabilizing therapeutic agent [J].
Chang, TW ;
Shiung, YY .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (06) :1203-1212
[9]
Identification of mast cell progenitors in adult mice [J].
Chen, CC ;
Grimbaldeston, MA ;
Tsai, M ;
Weissman, IL ;
Galli, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (32) :11408-11413
[10]
CLOHISY DR, 1987, J BIOL CHEM, V262, P15922